Found: 17
Select item for more details and to access through your institution.
Evaluation of the Effects of Repeat‐Dose Dabrafenib on the Single‐Dose Pharmacokinetics of Rosuvastatin (OATP1B1/1B3 Substrate) and Midazolam (CYP3A4 Substrate).
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 9, p. 1054, doi. 10.1002/cpdd.937
- By:
- Publication type:
- Article
BRAF activation by metabolic stress promotes glycolysis sensitizing NRAS<sup>Q61</sup>-mutated melanomas to targeted therapy.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34907-0
- By:
- Publication type:
- Article
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor‐induced liver injury.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 7, p. 865, doi. 10.1111/apt.17898
- By:
- Publication type:
- Article
Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26572-6
- By:
- Publication type:
- Article
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR.
- Published in:
- Nature Medicine, 2015, v. 21, n. 7, p. 741, doi. 10.1038/nm.3863
- By:
- Publication type:
- Article
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies.
- Published in:
- Nature Genetics, 2015, v. 47, n. 3, p. 250, doi. 10.1038/ng.3218
- By:
- Publication type:
- Article
Mucosal Melanoma Clinical Management and Prognostic Implications: A Retrospective Cohort Study.
- Published in:
- Cancers, 2024, v. 16, n. 1, p. 227, doi. 10.3390/cancers16010227
- By:
- Publication type:
- Article
Immune‐related hepatitis related to checkpoint inhibitors: Clinical and prognostic factors.
- Published in:
- Liver International, 2020, v. 40, n. 8, p. 1906, doi. 10.1111/liv.14489
- By:
- Publication type:
- Article
STK11 (LKB1) missense somatic mutant isoforms promote tumor growth, motility and inflammation.
- Published in:
- Communications Biology, 2020, v. 3, n. 1, p. 1, doi. 10.1038/s42003-020-1092-0
- By:
- Publication type:
- Article
SEOM-GEM clinical guidelines for cutaneous melanoma (2023).
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 11, p. 2841, doi. 10.1007/s12094-024-03497-2
- By:
- Publication type:
- Article
Access to melanoma drugs in Spain: a cross-sectional survey.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 10, p. 2572, doi. 10.1007/s12094-024-03501-9
- By:
- Publication type:
- Article
Contribution of tumour and immune cells to PD‐L1 expression as a predictive biomarker in metastatic triple‐negative breast cancer: exploratory analysis from KEYNOTE‐119.
- Published in:
- Journal of Pathology: Clinical Research, 2024, v. 10, n. 3, p. 1, doi. 10.1002/2056-4538.12371
- By:
- Publication type:
- Article
Hepatic sinusoidal obstruction syndrome associated with nivolumab: an uncommon adverse event related to immune checkpoint inhibitors.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Vollständiges Ansprechen eines metastasierten Plattenepithelkarzinoms der Haut und mehrerer multipler, lokal fortgeschrittener Basalzellkarzinome auf eine gleichzeitige Therapie mit Pembrolizumab und Sonidegib.
- Published in:
- Kompass Dermatologie, 2024, v. 12, n. 3, p. 188, doi. 10.1159/000539853
- By:
- Publication type:
- Article
NRAS-mutant melanoma: current challenges and future prospect.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 3941, doi. 10.2147/OTT.S117121
- By:
- Publication type:
- Article
Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 5345, doi. 10.2147/OTT.S325208
- By:
- Publication type:
- Article
Current Perspectives and Novel Strategies of NRAS-Mutant Melanoma.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 3709, doi. 10.2147/OTT.S278095
- By:
- Publication type:
- Article